C4X Discovery Holdings PLC
LSE:C4XD
Intrinsic Value
C4X Discovery Holdings Plc engages in the development of new technologies to improve the drug discovery process for novel small molecule therapies. [ Read More ]
The intrinsic value of one
C4XD
stock under the Base Case scenario is
41.306
GBX.
Compared to the current market price of 9.425 GBX,
C4X Discovery Holdings PLC
is
Undervalued by 77%.
C4XD's market price has consistently been higher than its intrinsic value.This persistent overvaluation suggests the market may be overly optimistic about
C4XD or that its price is influenced by factors unrelated to fundamentals.
C4X Discovery Holdings PLC's market capitalization is 23.8m GBX.
C4XD stock price is 9.425 GBX.
C4XD stock price (9.425 GBX) is 77% less than its Intrinsic Value (41.306 GBX).
C4XD. Open DCF Valuation
C4XD stock price (9.425 GBX) is 77% less than its Relative Value (41.306 GBX). Open Relative Valuation
C4XD has upside potential of 441% compared to the average analyst price target.
Open Wall St Estimates
C4XD's Revenue has grown by an exceptional 473% over the past 12 months.
C4XD's ROE (Return on Equity) has significantly increased in the last 3 years from -51% to 55%.
C4XD's ROIC (Return on Invested Capital) has significantly increased in the last 3 years from -158% to 128%.
C4XD has positive Operating Income for the last twelve months.
C4XD has positive Net Income for the last twelve months.
C4XD's ROE (Return on Equity) for the past 12 months is very high and is equal to 55%.
C4XD's ROIC (Return on Invested Capital) for the past 12 months is very high and is equal to 128%.
C4XD has positive Gross Profit for the last twelve months.
C4XD's Revenue is forecast to grow at a rate of 69% per year over the next 3 years.
C4XD has positive Free Cash Flow for the last twelve months.
C4XD's D/E (Debt to Equity) is very low and is equal to 0.
C4XD has negative three-year average ROE (Return on Equity): -40%. The company is not efficient at transforming stockholders' equity into net income.
C4XD has negative three-year average ROIC (Return on Invested Capital): -121%. The company is not efficient at using invested capital to generate operating income.
C4XD's short-term assets (25m GBP) exceed its short-term liabilties (2m GBP).
C4XD's long-term assets (26m GBP) exceed its long-term liabilties (2m GBP).
C4XD has negative Net Debt. This means that the company has more cash and short-term investments (13m GBP) than debt (5k GBP).
C4XD's Altman Z-Score is very high and is equal to 13.12.
Valuation Backtest
C4X Discovery Holdings PLC
Run backtest to discover the historical profit from buying and selling
C4XD
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
C4X Discovery Holdings PLC
Balance Sheet Decomposition
C4X Discovery Holdings PLC
| Current Assets | 24.7m |
| Cash & Short-Term Investments | 13.1m |
| Receivables | 11.6m |
| Non-Current Assets | 1.5m |
| PP&E | 275k |
| Intangibles | 1.2m |
| Current Liabilities | 1.6m |
| Accounts Payable | 1.4m |
| Other Current Liabilities | 253k |
| Non-Current Liabilities | 5k |
| Long-Term Debt | 5k |
Earnings Waterfall
C4X Discovery Holdings PLC
|
Revenue
|
24.7m
GBP
|
|
Cost of Revenue
|
-16k
GBP
|
|
Gross Profit
|
24.7m
GBP
|
|
Operating Expenses
|
-15.3m
GBP
|
|
Operating Income
|
9.4m
GBP
|
|
Other Expenses
|
1.2m
GBP
|
|
Net Income
|
10.6m
GBP
|
Free Cash Flow Analysis
C4X Discovery Holdings PLC
C4XD Profitability Score
Profitability Due Diligence
C4X Discovery Holdings PLC's profitability score is 45/100. The higher the profitability score, the more profitable the company is.
Score
C4X Discovery Holdings PLC's profitability score is 45/100. The higher the profitability score, the more profitable the company is.
C4XD Solvency Score
Solvency Due Diligence
C4X Discovery Holdings PLC's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
C4X Discovery Holdings PLC's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
C4XD Price Targets Summary
C4X Discovery Holdings PLC
According to Wall Street analysts, the average 1-year price target for
C4XD
is 51 GBX
with a low forecast of 48.48 GBX and a high forecast of 54.6 GBX.
Shareholder Return
C4XD Price
C4X Discovery Holdings PLC
| Average Annual Return | 2.26% |
| Standard Deviation of Annual Returns | 82.36% |
| Max Drawdown | -87% |
| Market Capitalization | 23.8m GBX |
| Shares Outstanding | 252 227 008 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
C4X Discovery Holdings PLC
Country
Industry
Market Cap
Dividend Yield
Description
C4X Discovery Holdings Plc engages in the development of new technologies to improve the drug discovery process for novel small molecule therapies. The firm operates by early commercial partnering or initiation of a its drug discovery program to develop a small molecule. The firm also works in collaboration with partners. The firm has a portfolio ranging from early stage-target to late-stage drug discovery program ready for out-licensing to partners. The Company’s portfolio of pre-clinical small molecule candidates includes Oral NRF2 activator, Oral MALT1 inhibitor, Oral α4β7 integrin inhibitor, Oral Orexin-1 Antagonist (C4X_3256/INDV-2000), Oral IL-17A Inhibitor. The company has developed activators of the NRF2 pathway for the treatment of a variety of inflammatory diseases including Inflammatory Bowel Disease (IBD), Sickle Cell Disease (SCD), Pulmonary Arterial Hypertension (PAH) and Chronic Obstructive Pulmonary Disorder (COPD).
Contact
IPO
Employees
Officers
The intrinsic value of one
C4XD
stock under the Base Case scenario is
41.306
GBX.
Compared to the current market price of 9.425 GBX,
C4X Discovery Holdings PLC
is
Undervalued by 77%.
You don't have any saved screeners yet
